title: [Long-term management of anemia in chronic inflammatory bowel disease].
abstract: The development of a stepwise therapy, as detailed below, can be administered to the mostly young patients with Crohn's disease and ulcerative colitis on an out-patient basis and appropriate to their needs. This is true not only for the activity of the disease, but also for extraintestinal manifestations. The numerous variations in the stepwise anti-inflammatory therapy of chronic inflammatory bowel disease, but also in the substitution therapy of deficiency states and the therapy of accompanying extraintestinal diseases provide the gastroenterologist with the possibility of a long-term treatment tailored to the needs of the individual patient.
authors.affiliation: Gastroenterologische Schwerpunktpraxis, Mannheim, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Mickisch
authors.forename: W
authors.initials: W
authors.lastname: Baniewicz
authors.forename: A
authors.initials: A
authors.lastname: Lutz-Vorderbrügge
authors.forename: S
authors.initials: S
authors.lastname: Schreiber
authors.forename: B
authors.initials: B
authors.lastname: Küppers
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000209:etiology / Q000628:therapy*; D003093:Colitis, Ulcerative / Q000150:complications / Q000628:therapy*; D003424:Crohn Disease / Q000150:complications / Q000628:therapy*; D004921:Erythropoietin / Q000008:administration & dosage*; D005290:Ferric Compounds / Q000008:administration & dosage*; D005296:Ferrous Compounds / Q000008:administration & dosage*; D006801:Humans; D011994:Recombinant Proteins
chemical_list: D005290:Ferric Compounds; D005296:Ferrous Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin